United States · FDA National Drug Code directory
Lamotrigine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62332-040_8154fe23-76e8-41b4-9c7a-1949e98bb703
- Product NDC
- 62332-040
- Form
- TABLET
- Composition / generic term
- Lamotrigine
- Labeler
- Alembic Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180205
- Source listing expiry
- 20271231
Source-listed ingredients
- LAMOTRIGINE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (62332-040-30) · 62332-040-30
- 60 TABLET in 1 BOTTLE (62332-040-60) · 62332-040-60
- 100 TABLET in 1 BOTTLE (62332-040-71) · 62332-040-71
- 1000 TABLET in 1 BOTTLE (62332-040-91) · 62332-040-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →